{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:29:48Z","timestamp":1793996988707,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.metabol.2020.154351","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:07:02Z","timestamp":1599210422000},"page":"154351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study"],"prefix":"10.1016","volume":"112","author":[{"given":"Albert","family":"Prats-Uribe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Sayols-Baixeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Fern\u00e1ndez-Sanl\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Subirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Carreras-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Vilahur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Marrugat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Fit\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Hern\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Elosua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154351_bb0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154351_bb0010","doi-asserted-by":"crossref","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","author":"Keene","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2020.154351_bb0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2020.154351_bb0020","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/eurheartj\/ehy299","article-title":"HDL-cholesterol, genetics, and coronary artery disease: the myth of the \u2018good cholesterol?\u2019","volume":"39","author":"Landmesser","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2020.154351_bb0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/ATVBAHA.117.307025","article-title":"From high-density lipoprotein cholesterol to measurements of function","volume":"38","author":"Sacks","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2020.154351_bb0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacl.2012.03.001","article-title":"High-density lipoprotein subclasses and their relationship to cardiovascular disease","volume":"6","author":"Superko","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.metabol.2020.154351_bb0035","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154351_bb0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI5286","article-title":"Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men","volume":"103","author":"Lamarche","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154351_bb0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11745-010-3408-1","article-title":"Atherogenic dyslipidemia: cardiovascular risk and dietary intervention","volume":"45","author":"Musunuru","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.metabol.2020.154351_bb0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in Mendelian randomization studies","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Reports"},{"key":"10.1016\/j.metabol.2020.154351_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.atherosclerosis.2020.02.002","article-title":"Apolipoprotein A-I concentrations and risk of coronary artery disease: a Mendelian randomization study","volume":"299","author":"Karjalainen","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2020.154351_bb0060","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2013.07.085","article-title":"Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies","volume":"62","author":"W\u00fcrtz","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2020.154351_bb0065","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2020.154351_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"CARDIoGRAMplusC4D Consortium P","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2020.154351_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007079","article-title":"Common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM study","volume":"13","author":"Davis","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2020.154351_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.metabol.2020.154351_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-02317-2","article-title":"Causal associations between risk factors and common diseases inferred from GWAS summary data","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2020.154351_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","article-title":"GCTA: a tool for genome-wide complex trait analysis","volume":"88","author":"Yang","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2020.154351_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature15394","article-title":"An integrated map of structural variation in 2,504 human genomes","volume":"526","author":"Sudmant","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154351_bb0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2020.154351_bb0105","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2020.154351_bb0110","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2020.154351_bb0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/ATVBAHA.115.306268","article-title":"Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects","volume":"36","author":"Ronsein","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2020.154351_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.atherosclerosis.2019.04.211","article-title":"Evacetrapib reduces pre\u03b2-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes","volume":"285","author":"Chen","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2020.154351_bb0125","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.285.12.1585","article-title":"Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial","volume":"285","author":"Robins","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2020.154351_bb0130","doi-asserted-by":"crossref","unstructured":"Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science (80-) 2016;351:1166\u201371. https:\/\/doi.org\/10.1126\/science.aad3517.","DOI":"10.1126\/science.aad3517"},{"key":"10.1016\/j.metabol.2020.154351_bb0135","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial","volume":"113","author":"Otvos","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2020.154351_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial","volume":"90","author":"Rosenson","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2020.154351_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2020.154351_bb0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1373\/clinchem.2009.140939","article-title":"Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size","volume":"56","author":"Arsenault","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2020.154351_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCRESAHA.114.300632","article-title":"Regulation of high-density lipoprotein metabolism","volume":"114","author":"Rye","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2020.154351_bb0160","doi-asserted-by":"crossref","first-page":"26910","DOI":"10.1074\/jbc.270.45.26910","article-title":"Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability","volume":"270","author":"Sparks","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154351_bb0165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.ajpath.2010.12.050","article-title":"Hepatic lipase, high density lipoproteins, and hypertriglyceridemia","volume":"178","author":"Chatterjee","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2020.154351_bb0170","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154351_bb0175","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.ATV.12.9.1044","article-title":"Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes","volume":"12","author":"Miettinen","year":"1992","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2020.154351_bb0180","doi-asserted-by":"crossref","first-page":"22453","DOI":"10.1016\/S0021-9258(18)45726-2","article-title":"Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein","volume":"265","author":"Weisgraber","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154351_bb0185","doi-asserted-by":"crossref","first-page":"37504","DOI":"10.1074\/jbc.M007210200","article-title":"Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity","volume":"275","author":"Gautier","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154351_bb0190","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1194\/jlr.P058032","article-title":"PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity","volume":"56","author":"Kim","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2020.154351_bb0195","first-page":"11195","article-title":"Association of the TTC39B rs581080 SNP and serum lipid levels and the risk of coronary artery disease and ischemic stroke","volume":"10","author":"Huang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.metabol.2020.154351_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2017.10.006","article-title":"Challenges in interpreting multivariable Mendelian randomization: might \u201cgood cholesterol\u201d be good after all?","volume":"71","author":"Holmes","year":"2018","journal-title":"Am J Kidney Dis"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520302158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520302158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:23:30Z","timestamp":1758428610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520302158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"alternative-id":["S0026049520302158"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154351","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/673939","asserted-by":"object"}]},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154351"}}